KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Incyte (INCY) over the last 16 years, with Sep 2025 value amounting to $2.5 billion.

  • Incyte's Cash & Equivalents rose 88.25% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year increase of 88.25%. This contributed to the annual value of $1.7 billion for FY2024, which is 47.47% down from last year.
  • Incyte's Cash & Equivalents amounted to $2.5 billion in Q3 2025, which was up 25.58% from $2.0 billion recorded in Q2 2025.
  • Over the past 5 years, Incyte's Cash & Equivalents peaked at $3.3 billion during Q1 2024, and registered a low of $987.3 million during Q2 2024.
  • In the last 3 years, Incyte's Cash & Equivalents had a median value of $2.5 billion in 2025 and averaged $2.4 billion.
  • As far as peak fluctuations go, Incyte's Cash & Equivalents crashed by 68.47% in 2024, and later surged by 98.01% in 2025.
  • Over the past 5 years, Incyte's Cash & Equivalents (Quarterly) stood at $2.1 billion in 2021, then soared by 43.45% to $3.0 billion in 2022, then rose by 8.88% to $3.2 billion in 2023, then slumped by 47.47% to $1.7 billion in 2024, then surged by 88.25% to $2.5 billion in 2025.
  • Its last three reported values are $2.5 billion in Q3 2025, $2.0 billion for Q2 2025, and $1.9 billion during Q1 2025.